Kura Oncology (KURA) Short Interest Ratio & Short Volume → Urgent Alert: Is the U.S. Implementing a Digital Dollar? (From Gold Gate Capital) (Ad) Free KURA Stock Alerts $19.62 -0.44 (-2.19%) (As of 04/30/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Kura Oncology Short Interest DataCurrent Short Volume10,120,000 sharesPrevious Short Volume10,410,000 sharesChange Vs. Previous Month-2.79%Dollar Volume Sold Short$192.38 millionShort Interest Ratio / Days to Cover7.2Last Record DateApril 15, 2024Outstanding Shares76,180,000 sharesFloat Size63,540,000 sharesShort Percent of Float15.93%Today's Trading Volume545,719 sharesAverage Trading Volume1,308,500 sharesToday's Volume Vs. Average42% Short Selling Kura Oncology ? Sign up to receive the latest short interest report for Kura Oncology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatKURA Short Interest Over TimeKURA Days to Cover Over TimeKURA Percentage of Float Shorted Over Time Ad True Market InsidersThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeThe man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 Kura Oncology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202410,120,000 shares $192.38 million -2.8%15.9%7.2 $19.01 3/31/202410,410,000 shares $222.05 million +1.1%16.4%7.4 $21.33 3/15/202410,300,000 shares $230.10 million -6.5%16.2%7.3 $22.34 2/29/202411,020,000 shares $232.30 million +4.9%17.4%7 $21.08 2/15/202410,510,000 shares $215.56 million +12.2%16.3%7.1 $20.51 1/31/20249,370,000 shares $188.71 million No Change14.3%6.2 $20.14 Get the Latest News and Ratings for KURA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kura Oncology and its competitors with MarketBeat's FREE daily newsletter. 1/15/20249,370,000 shares $144.02 million +1.2%14.3%9.4 $15.37 12/31/20239,260,000 shares $133.16 million -15.9%14.1%8.9 $14.38 12/15/202311,010,000 shares $135.42 million -0.6%16.7%11.1 $12.30 11/30/202311,080,000 shares $107.14 million +1.9%16.8%14.3 $9.67 11/15/202310,870,000 shares $101.96 million +7.6%16.5%14.5 $9.38 10/31/202310,100,000 shares $85.35 million +38.6%15.3%15.4 $8.45 10/15/20237,290,000 shares $61.53 million +4.1%11.1%11.4 $8.44 9/30/20237,000,000 shares $63.84 million +9.9%10.6%12.2 $9.12 9/15/20236,370,000 shares $63.00 million +3.8%9.7%10.3 $9.89 8/31/20236,140,000 shares $60.97 million -1.4%N/A7.8 $9.93 8/15/20236,230,000 shares $72.95 million +3.0%N/A7.2 $11.71 7/31/20236,050,000 shares $63.16 million -4.1%N/A6.8 $10.44 7/15/20236,310,000 shares $63.35 million +1.3%N/A7.1 $10.04 6/30/20236,230,000 shares $65.91 million -16.3%N/A7.2 $10.58 6/15/20237,440,000 shares $81.54 million +21.2%N/A9 $10.96 5/31/20236,140,000 shares $81.78 million -21.8%9.6%9.6 $13.32 5/15/20237,850,000 shares $99.38 million -0.4%12.4%12.5 $12.66 4/30/20237,880,000 shares $76.75 million -0.1%12.5%13.4 $9.74 4/15/20237,890,000 shares $90.26 million -3.8%12.5%12.9 $11.44 3/31/20238,200,000 shares $100.29 million +15.5%15.3%12.8 $12.23 3/15/20237,100,000 shares $83.00 million +0.1%11.0%10.6 $11.69 2/28/20237,090,000 shares $84.51 million +5.4%11.0%8.6 $11.92 2/15/20236,730,000 shares $81.37 million +1.1%10.5%8.1 $12.09 1/31/20236,660,000 shares $92.04 million +5.4%10.3%7.5 $13.82 1/15/20236,320,000 shares $90.38 million -2.5%9.8%6.2 $14.30 12/30/20226,480,000 shares $80.42 million +2.4%10.0%6.2 $12.41 12/15/20226,330,000 shares $80.39 million -11.5%9.8%5.7 $12.70 11/30/20227,150,000 shares $112.76 million +2.4%11.1%6.8 $15.77 11/15/20226,980,000 shares $106.79 million +11.0%10.8%6.9 $15.30 10/31/20226,290,000 shares $97.62 million -12.6%9.8%6.6 $15.52 10/15/20227,200,000 shares $108.79 million -3.5%11.4%8.1 $15.11 9/30/20227,460,000 shares $101.90 million -7.8%11.8%8.4 $13.66 9/15/20228,090,000 shares $118.11 million -0.4%12.8%9.5 $14.60 8/31/20228,120,000 shares $112.54 million +4.5%12.8%10 $13.86the harsh reality of the stock market (Ad)OK, you’re not supposed to say this In fact, maverick investor Graham Lindman says it’s become the silent elephant in the room that everyone is pretending isn’t there. But he just said it: Most stocks suck. And he isn’t saying that figuratively or subjectively… You see, 96% of stocks underperform. Just 4% of “Apex Stocks” generate virtually all the wealth.All you have to do is watch here for all the details. KURA Short Interest - Frequently Asked Questions What is Kura Oncology's current short interest? Short interest is the volume of Kura Oncology shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 10,120,000 shares of KURA short. 15.93% of Kura Oncology's shares are currently sold short. Learn More on Kura Oncology's current short interest. What is a good short interest ratio for Kura Oncology? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KURA shares currently have a short interest ratio of 7.0. Learn More on Kura Oncology's short interest ratio. Which institutional investors are shorting Kura Oncology? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Kura Oncology: Simplex Trading LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Kura Oncology? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 15.93% of Kura Oncology's floating shares are currently sold short. Is Kura Oncology's short interest increasing or decreasing? Kura Oncology saw a decline in short interest during the month of April. As of April 15th, there was short interest totaling 10,120,000 shares, a decline of 2.8% from the previous total of 10,410,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Kura Oncology's float size? Kura Oncology currently has issued a total of 76,180,000 shares. Some of Kura Oncology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Kura Oncology currently has a public float of 63,540,000 shares. How does Kura Oncology's short interest compare to its competitors? 15.93% of Kura Oncology's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Kura Oncology: Morphic Holding, Inc. (12.48%), Arcus Biosciences, Inc. (14.45%), Akero Therapeutics, Inc. (11.83%), Day One Biopharmaceuticals, Inc. (15.17%), Edgewise Therapeutics, Inc. (9.15%), ANI Pharmaceuticals, Inc. (1.01%), Ardelyx, Inc. (14.58%), Gyre Therapeutics, Inc. (1.30%), Zai Lab Limited (4.11%), Dynavax Technologies Co. (14.17%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Kura Oncology stock? Short selling KURA is an investing strategy that aims to generate trading profit from Kura Oncology as its price is falling. KURA shares are trading down $0.44 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Kura Oncology? A short squeeze for Kura Oncology occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of KURA, which in turn drives the price of the stock up even further. How often is Kura Oncology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KURA, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: MORF Short Interest Data RCUS Short Interest Data AKRO Short Interest Data DAWN Short Interest Data EWTX Short Interest Data ANIP Short Interest Data ARDX Short Interest Data GYRE Short Interest Data ZLAB Short Interest Data DVAX Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KURA) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersThe Gold Grab of the CenturyColonial MetalsProtect Your Bank Account Before It’s Too LateWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsIs Tesla going out of business?DTITrump’s last act as President Porter & CompanyThe A.I. story nobody is telling you (Read ASAP)TradeSmithElon Musk Secret Crypto Plot ExposedCrypto 101 MediaREAD THIS – If You Missed Out On The AI BoomBanyan Hill Publishing